BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Papanagnou P, Stivarou T, Papageorgiou I, Papadopoulos GE, Pappas A. Marketed drugs used for the management of hypercholesterolemia as anticancer armament. Onco Targets Ther 2017;10:4393-411. [PMID: 28932124 DOI: 10.2147/OTT.S140483] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Papanagnou P, Papadopoulos GE, Stivarou T, Pappas A. Toward fully exploiting the therapeutic potential of marketed pharmaceuticals: the use of octreotide and chloroquine in oncology. Onco Targets Ther 2019;12:319-39. [PMID: 30643430 DOI: 10.2147/OTT.S182685] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
2 Ermolenko EV, Imbs AB, Gloriozova TA, Poroikov VV, Sikorskaya TV, Dembitsky VM. Chemical Diversity of Soft Coral Steroids and Their Pharmacological Activities. Mar Drugs 2020;18:E613. [PMID: 33276570 DOI: 10.3390/md18120613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Rodríguez-Miguel A, Fernández-Antón E, Barreira-Hernández D, García-Rodríguez LA, Gil M, García-Lledó A, De Abajo FJ. Statins and Colorectal Cancer Risk: A Population-Based Case-Control Study and Synthesis of the Epidemiological Evidence. J Clin Med 2022;11:1528. [PMID: 35329853 DOI: 10.3390/jcm11061528] [Reference Citation Analysis]